spacer
home > ebr > spring 2019 > trusting in biobanking
PUBLICATIONS
European Biopharmaceutical Review

Trusting in Biobanking

Biobanking is used to create large scale repositories of human biological material, such as blood, urine, tissue, and DNA, to further medical research. Research institutes, hospitals, and biopharmaceutical and biotechnology companies rely on biobanks to advance research of new therapies and for the identification of disease biomarkers from large patient cohorts. Biobanking supports a number of modern research techniques, including genomics and personalised medicine, by allowing researchers to better understand who is most at risk of certain diseases and what treatments they may best respond to. A number of biobanks exist worldwide, each containing hundreds of thousands of samples to contribute to the growing pool of knowledge and safeguarding public health in future generations.

Nuclear Magnetic Resonance and Biobanking

Sample collection, preparation, analysis, storage, transport, and data management must all be highly standardised in biobanking. Samples that are stored over decades can change, and researchers can never guarantee that a sample will remain unchanged over time. The high reproducibility of nuclear magnetic resonance (NMR) spectroscopy makes it an important analytical tool for biobank samples. It can characterise stored samples and determine whether any changes could lead to artefacts.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Matthias Nauck is a Professor at the Institute of Clinical Chemistry at University Medicine Greifswald, Germany. His role is split between a focus on patient care and a range of scientific research projects. Matthias has played an integral role in introducing NMR to the lab at Greifswald for epidemiological research and biobanking studies.
spacer
Matthias Nauck
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Bonfiglioli Engineering Headspace Gas Analysis Systems for Parenteral Manufacturing Processes: One Step Beyond Product Quality and Patient Safety

Bonfiglioli Engineering

This white paper presents the innovative solutions that Bonfiglioli Engineering has been developing in the field of HGA and their significant advantages over other existing systems.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement